Childress Capital Advisors, LLC Amgen Inc Transaction History

Childress Capital Advisors, LLC

$349 Million
Q2 2024

A detailed history of Childress Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 1,982 shares of AMGN stock, worth $638,620. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,982

Previous 1,888 4.98%

Holding current value

$638,620

Previous $536,000 15.49%

% of portfolio

0.18%

Previous 0.16%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $24,698 - $30,015	94 Added 4.98%	1,982 $619,000
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $29,037 - $35,052	-108 Reduced 5.41%	1,888 $536,000
Q4 2023 Feb 16, 2024	BUY	$255.7 - $288.46 $511 - $576	2 Added 0.1%	1,996 $574,000
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $435,988 - $541,291	1,994 New	1,994 $535,000
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $69,396 - $88,176	-303 Reduced 13.13%	2,005 $526,000
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $19,752 - $22,277	88 Added 3.96%	2,308 $536,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $29,069 - $32,349	126 Added 6.02%	2,220 $540,000
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $39,907 - $44,147	182 Added 9.52%	2,094 $507,000
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $56,084 - $64,183	282 Added 17.3%	1,912 $430,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $11,038 - $12,932	52 Added 3.3%	1,630 $352,000
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $130,104 - $144,340	-557 Reduced 26.09%	1,578 $384,000
Q1 2021 May 21, 2021	BUY	$221.91 - $258.6 $149,345 - $174,037	673 Added 46.03%	2,135 $531,000
Q4 2020 Mar 09, 2021	BUY	$216.38 - $257.67 $316,347 - $376,713	1,462 New	1,462 $336,000

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Childress Capital Advisors, LLC with notifications on news.

Account

Childress Capital Advisors, LLC Amgen Inc Transaction History